Michael Oredsson, chief executive at Probi AB, has been named president and chief executive officer at BioInvent International AB, which is developing antibody-based therapeutics against cancer. Mr Oredsson has a degree in international business administration and has for many years held executive positions in the pharmaceutical and biotech industries including at Pharmacia Corporation (Pfizer).
BioInvent announced the appointment on 24 May 2013.
Copyright 2013 Evernow Publishing Ltd